Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- ChecktodayChange DetectedA new identifier, '2023 ( U.S. NIH Grant/Contract )', was added under the study's Other Study ID Numbers to reflect NIH funding/identification associated with the trial.SummaryDifference0.0%

- Check7 days agoChange DetectedRecruitment status changed to Completed as of 2026-08-17, indicating enrollment across sites has ended. This reflects a milestone update on the study page relevant to participants and researchers.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates a small platform/template update rather than a change to study information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record status is now Recruiting as of 2026-07-20, replacing the previous Withdrawn status. The page has been updated with a newer last update date and revision (v3.6.4).SummaryDifference0.1%

- Check57 days agoChange DetectedExpanded the study's locations to 84 sites with new entries such as Hospital Universitario de Donostia and Herlev Hospital, and updated the contact/inquiry information for participant questions.SummaryDifference0.7%

- Check71 days agoChange DetectedThe page now includes new quick-access links for Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study to aid navigation. The Intervention/Treatment header formatting has been standardized (replacing the earlier 'Intervention / Treatment'), and the revision label updated to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.